2015
DOI: 10.1007/s13361-014-1060-3
|View full text |Cite
|
Sign up to set email alerts
|

Metabolomic Discovery of Novel Urinary Galabiosylceramide Analogs as Fabry Disease Biomarkers

Abstract: Abstract. Fabry disease is an X-linked, complex, multisystemic lysosomal storage disorder presenting marked phenotypic and genotypic variability among affected male and female patients. Glycosphingolipids, mainly globotriaosylceramide (Gb 3 ) isoforms/analogs, globotriaosylsphingosine (lyso-Gb 3 ) and analogs, as well as galabiosylceramide (Ga 2 ) isoforms/analogs accumulate in the vascular endothelium, nerves, cardiomyocytes, renal glomerular and tubular epithelial cells, and biological fluids. The search for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
43
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
10

Relationship

7
3

Authors

Journals

citations
Cited by 44 publications
(47 citation statements)
references
References 26 publications
1
43
0
Order By: Relevance
“…The hypothesis that increased levels of plasma and (possibly) urinary lyso-Gb 3 analog at m/z 836 are an earlier biomarker of progressive heart disease, and that urinary excretion of Gb 3 is a specific biomarker of FD nephropathy, warrants further research studies [74] with larger, carefully selected cardiac and renal patient cohorts.…”
Section: Discussionmentioning
confidence: 99%
“…The hypothesis that increased levels of plasma and (possibly) urinary lyso-Gb 3 analog at m/z 836 are an earlier biomarker of progressive heart disease, and that urinary excretion of Gb 3 is a specific biomarker of FD nephropathy, warrants further research studies [74] with larger, carefully selected cardiac and renal patient cohorts.…”
Section: Discussionmentioning
confidence: 99%
“…These amphiphilic molecules composed of a glycan head group and ceramide backbone are involved in protein interaction, receptor regulation, initiation and modulation of signal transduction, as well as cell recognition and differentiation [2]. Given these, perturbations in glycosphingolipid metabolism have been recognized as hallmark in a myriad of pathologies including neurological [4, 5], autoimmune [6], and lysosomal storage diseases [7] among others. Recent literature also indicates their potential use as therapeutic agents in cancer and autoimmune diseases due to their immunogenic characteristics [8].…”
Section: Introductionmentioning
confidence: 99%
“…Our ability to convert sulfatides to a derivative that can be analyzed in positive-ion MS/MS is expected to be valuable for multiplexing NBS of MLD with other diseases, including a panel of lysosomal storage diseases for which we have developed highly robust NBS assays in positive-ion mode (15). UHPLC-MS/MS in positive-ion mode can be used to simultaneously monitor the activity of several enzymes and a panel of biomarkers; for example, psychosine for Krabbe disease (16, 17), lyso-Gb 3 for Fabry disease (18), glucosylsphingosine for Gaucher disease (19), and sulfatides for MLD. This will be possible with inject-to-inject times that are short enough for NBS.…”
Section: Discussionmentioning
confidence: 99%